Descriptor English: | Enoxaparin | ||||
Descriptor Spanish: |
Enoxaparina
| ||||
Descriptor Portuguese: | Enoxaparina | ||||
Descriptor French: | Énoxaparine | ||||
Entry term(s): |
Clexane EMT 966 EMT 967 EMT-966 EMT-967 EMT966 EMT967 Enoxaparine Lovenox PK 10,169 PK 10169 PK-10,169 PK-10169 PK10,169 PK10169 |
||||
Tree number(s): |
D09.698.373.400.300.200 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017984 | ||||
Scope note: | Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed) |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||
Pharm Action: |
Anticoagulants Fibrinolytic Agents |
||||
Public MeSH Note: | 92; was heading 1992-93; was see HEPARIN, LOW MOLECULAR WEIGHT 1990-91 |
||||
Online Note: | use HEPARIN, LOW-MOLECULAR-WEIGHT to search ENOXAPARIN 1990-93 |
||||
History Note: | 94; was heading 1992-93; was see HEPARIN, LOW-MOLECULAR-WEIGHT 1990-91 |
||||
DeCS ID: | 31485 | ||||
Unique ID: | D017984 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1994/01/01 | ||||
Date of Entry: | 1993/06/04 | ||||
Revision Date: | 2005/06/30 |
-
-
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates
|
Enoxaparin
- Preferred
PK-10,169
- Narrower
EMT-967
- Narrower
Lovenox
- Narrower
Clexane
- Narrower
EMT-966
- Narrower
Concept UI |
M0027160 |
Scope note | Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed) |
Preferred term | Enoxaparin |
Entry term(s) |
Enoxaparine |
Concept UI |
M0357374 |
Preferred term | PK-10,169 |
Entry term(s) |
PK 10,169 PK 10169 PK-10169 PK10,169 PK10169 |
Concept UI |
M0027159 |
Preferred term | EMT-967 |
Entry term(s) |
EMT 967 EMT967 |
Concept UI |
M0357375 |
Preferred term | Lovenox |
Concept UI |
M0027161 |
Preferred term | Clexane |
Concept UI |
M0027158 |
Preferred term | EMT-966 |
Entry term(s) |
EMT 966 EMT966 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey